GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
5XMH | P0DOX5 | Crystal structure of an IgM rheumatoid factor YES8c in complex with IgG1 Fc | |
6BZ4 | P0DOX5 | Human IgG1 lacking complement-dependent cytotoxicity: hu3S193 Fc mutant K322A | |
6MUB | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
6MUB | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man5 re-refinement | |
6UGY | P0DOX5 | Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C | |
6UGY | P0DOX5 | Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C | |
6X3I | P0DOX5 | NNAS Fc mutant | |
7CZV | P0DOX5 | S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B | |
7CZV | P0DOX5 | S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B | |
6KA7 | P0DOX5 | The complex structure of Human IgG Fc and its binding Repebody | |
6UGX | P0DOX5 | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A | |
6UGX | P0DOX5 | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A | |
6YSC | P0DOX5 | GLYCOSYLATED KNOB-HOLE/DUMMY FC FRAGMENT | |
5WAV | P0DOX5 | Fc AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery. | |
5WAV | P0DOX5 | Fc AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery. | |
6BKB | P0DOX5 | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3A | |
6BKB | P0DOX5 | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3A | |
6BKC | P0DOX5 | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B | |
6BKC | P0DOX5 | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B | |
6MSY | P0DOX5 | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
6MSY | P0DOX5 | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
6N35 | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement | |
6N35 | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man1-2 re-refinement | |
6VSL | P0DOX5 | Crystal structure of a human fucosylated IgG1 Fc expressed in tobacco plants (Nicotiana benthamiana) | |
6YTB | P0DOX5 | GLYCOSYLATED KNOB/DUMMY-HOLE/DUMMY FC FRAGMENT | |
5Y56 | P0DOX5 | Fc mutant (K392D/K409D/D399K) | |
6IFJ | P0DOX5 | Structure of bispecific Fc | |
6IQG | P0DOX5 | X-ray crystal structure of Fc and peptide complex | |
6MU3 | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
6MU3 | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
6UGW | P0DOX5 | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A | |
6UGW | P0DOX5 | Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A | |
1HZH | P0DOX5 | CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | |
1HZH | P0DOX5 | CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | |
3PGF | P0DOX5 | Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB) | |
3PGF | P0DOX5 | Crystal structure of maltose bound MBP with a conformationally specific synthetic antigen binder (sAB) | |
4R2G | P0DOX5 | Crystal Structure of PGT124 Fab bound to HIV-1 JRCSF gp120 core and to CD4 | Surface protein gp160, T-cell surface glycoprotein CD4, PGT124 Heavy Chain, PGT124 Light Chain |
4R2G | P0DOX5 | Crystal Structure of PGT124 Fab bound to HIV-1 JRCSF gp120 core and to CD4 | Surface protein gp160, T-cell surface glycoprotein CD4, PGT124 Heavy Chain, PGT124 Light Chain |
5O4E | P0DOX5 | Crystal structure of VEGF in complex with heterodimeric Fcab JanusCT6 | |
5YC5 | P0DOX5 | Crystal structure of human IgG-Fc in complex with aglycan and optimized Fc gamma receptor IIIa | |
6N2X | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man9 re-refinement | |
6N2X | P0DOX5 | Anti-HIV-1 Fab 2G12 + Man9 re-refinement | |
6V8Z | P0DOX5 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | |
6V8Z | P0DOX5 | VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure | |
6VSZ | P0DOX5 | Crystal structure of a human afucosylated IgG1 Fc expressed in tobacco plants (Nicotiana benthamiana) | |
6YT7 | P0DOX5 | GLYCOSYLATED KNOB/DUMMY-HOLE FC FRAGMENT | |
8DV1 | P0DOX5 | SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432 | |
8DV2 | P0DOX5 | SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293 | |
8GHR | P0DOX5 | Structure of human ENPP1 in complex with variable heavy domain VH27.2 | |
8W4L | P0DOX5 | Crystal structure of closed conformation of human immunoglobulin Fc in presence of EndoSz |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024